Synthesis and anticonvulsant activity of amino acid-derived sulfamides

Journal of Medicinal Chemistry

Volumn 52, Issue 6, 2009, Pages 1592-1601

  Gavernet, Luciana ^a   Elvira, Juan E ^a   Samaja, Gisela A ^a   Pastore, Valentina ^a   Cravero, Mariana Sella ^c   Enrique, Andrea ^a   Estiu, Guillermina ^b   Bruno Blanch, Luis E ^a  

^a UNIVERSIDAD NACIONAL DE LA PLATA   (Argentina)

^b UNIVERSITY OF NOTRE DAME   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYPHENYL N BETA ALANINE METHYL ESTER SULFAMATE; AMINO ACID; METHYL [N (N' 2 PROPYLPENTYL)SULFAMOYL]GLYCINATE; METHYL [N (N' 2 PROPYLPENTYL, N' TERT BUTOXYCARBONYL)SULFAMOYL]BETA ALANINATE; METHYL [N (N' 2 PROPYLPENTYL, N' TERT BUTOXYCARBONYL)SULFAMOYL]GLYCINATE; METHYL [N (N' BENZYL, N' TERT BUTOXYCARBONYL)SULFAMOYL]GLYCINATE; METHYL [N (N' TERT BUTOXYCARBONYL)SULFAMOYL]ALANINATE; METHYL [N (N' TERT BUTOXYCARBONYL)SULFAMOYL]BETA ALANINATE; METHYL [N (N' TERT BUTOXYCARBONYL)SULFAMOYL]GLYCINATE; METHYL [N (N'BUTYL)SULFAMOYL]BETA ALANINATE; METHYL[N (N' 2 PROPYLPENTYL)SULFAMOYL]BETA ALANINATE; METHYL[N (N' BENZYL)SULFAMOYL]BETA ALANINATE; METHYL[N (N' BENZYL)SULFAMOYL]GLYCINATE; METHYL[N (N' CYCLOHEXYL)SULFAMOYL]BETA ALANINATE; N,N' SULFONYL BIS ALANINE DIMETHYL ESTER; N,N' SULFONYL BIS BETA ALANINE DIMETHYL ESTER; N,N' SULFONYL BIS VALINE DIMETHYL ESTER; SULFANILAMIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DESIGN; DRUG SYNTHESIS; EPILEPSY; MALE; MOUSE; NONHUMAN;

AMIDES; ANTICONVULSANTS; MAGNETIC RESONANCE SPECTROSCOPY; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 64349083353     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm800764p     Document Type: Article

References (46)

1. Bell, G. S.; Sander, J. W. The epidemiology of epilepsy: the size of the problem. Seizure 2002, 11 (Suppl. A), 306-314.
2. Lopes Lima, J. M. The new drugs and strategies to manage epilepsy. Curr. Pharmac. Des. 2000, 6, 873-878.
3. Perucca, E. Marketed new antiepileptic drugs: are they better than old-generation agents? Ther. Drug Monit. 2002, 24, 74-80.
4. Berk, M.; Segal, J.; Janet, L.; Vorster, M. Emerging options in the treatment of bipolar disorders. Drugs 2001, 61, 1407-1414.
5. Epilepsy: scientific and medical advances; WHO Fact Sheet No.167; World Health Organization: Geneva, 2001; http://www.who.int/mediacentre/factsheets/ fs167.
6. Löscher, W. Drug transporters in the epileptic brain. Epilepsia 2007, 48, 8-13.
7. Zaccara, G.; Franciotta, D.; Perucca, E. Idiosyncratic adverse reactions to antiepileptic drugs. Epilepsia 2007, 48, 1223-1244.
8. Bialer, M.; Johannessen, S. I.; Kupferberg, H. J.; Levy, R. H.; Perucca, E.; Tomson, T. Progress report on new antiepileptic drugs: a summary of the Eighth Eilat Conference (EILAT VIII). Epilepsy Res. 2007, 73, 1-52.
9. Rogawski, M. A. Diverse mechanisms of antiepileptic drugs in the development pipeline. Epilepsy Res. 2006, 69, 273-294.
10. Yogeeswari, P.; Sriram, D.; Thirumurugan, R.; Raghavendran, J. V.; Sudhan, K.; Pavana, R. K.; Stables, J. Discovery of N-(2,6-dimeth- ylphenyl)-substituted semicarbazones as anticonvulsants: hybrid phar-macophore-based design. J. Med. Chem. 2005, 48, 6202-6211.
11. Malawska, B.; Kulig, K.; Spiewak, A.; Stables, J. P. Investigation into new anticonvulsant derivatives of α-substituted N-benzylamides of γ-hydroxy- and γ-acetoxybutyric acid. Part 5: Search for new anticonvulsant compounds. Bioorg. Med. Chem. 2004, 12, 625-632.
12. Tasso, S. M.; Moon, S. C.; Bruno-Blanch, L. E.; Estiú, G. L. Characterization of the anticonvulsant profile of valpromide derivatives. Bioorg. Med. Chem. 2004, 12, 3857-3869.
13. Wilson, T. L.; Jackson, P. L.; Hanson, C. D.; Xue, Z.; Eddington, N. D.; Scott, K. R. QSAR of the anticonvulsant enaminones; molecular modeling aspects and other assessments. Med. Chem. 2005, 1, 371-381.
14. Tasso, S. M.; Bruno-Blanch, L. E.; Moon, S. C.; Estiu, G. L. Pharmacophore searching and QSAR analysis in the design of anticonvulsant drugs. J. Mol. Struct. (THEOCHEM) 2000, 504, 229-240.
15. Lenkowski, P. W.; Batts, T. W.; Smith, M. D.; Ko, S.-H.; Jones, P. J.; Taylor, C. H.; McCusker, A. K.; Davis, G. C.; Hartmann, H. A.; White, H. S.; Brown, M. L.; Patel, M. K. A pharmacophore derived phenytoin analogue with increased affinity for slow inactivated sodium channels exhibits a desired anticonvulsant profile. Neuropharmacology 2007, 52, 1044-1054.
16. Gavernet, L.; Dominguez Cabrera, M. J.; Bruno-Blanch, L. E.; Estiú, G. L. 3D-QSAR design of novel antiepileptic sulfamides. Bioorg. Med. Chem. 2007, 15, 1556-1567.
17. Gavernet, L.; Barrios, I. A.; Sella Cravero, M.; Bruno-Blanch, L. E. Design, synthesis, and anticonvulsant activity of some sulfamides. Bioorg. Med. Chem. 2007, 15, 5604-5614.
18. Rogawski, M. A.; Löscher, W. The neurobiology of antiepileptic drugs. Nat. Rev. Neurosci. 2004, 5, 553-564.
19. Horwell, D. C.; Howson, W.; Ratcliffe, G. S.; Rees, D. C. The design of a dipeptide library for screening at peptide receptor sites. Bioorg. Med. Chem. Lett. 1993, 3, 799-802.
20. Conti, P.; De Amici, M.; di Ventimiglia, S. J.; Stensbøl, T. B.; Madsen, U.; Braüner-Osborne, H.; Russo, E.; De Sarro, G.; Bruno, G.; De Micheli, C. Synthesis and Anticonvulsant Activity of Novel Bicyclic Acidic Amino Acids. J. Med. Chem. 2003, 46, 3102-3108.
21. Yogeeswari, P.; Ragavendran, J. V.; Sriram, D.; Nageswari, Y.; Kavya, R.; Sreevatsan, N.; Vanitha, K.; Stables, J. Discovery of 4-Aminobu-tyric Acid Derivatives Possessing Anticonvulsant and Antinociceptive Activities: A Hybrid Pharmacophore Approach. J. Med. Chem. 2007, 50, 2459-2467.
22. Galemmo, R. A., Jr.; Wells, B. L.; Rossi, K. A.; Alexander, R. S.; Dominguez, C.; Maduskuie, T. P.; Stouten, P. F. W.; Wright, M. R.; Aungst, B. J.; Wong, P. C.; Knabb, R. M.; Wexler, R. R. The de novo design and synthesis of cyclic urea inhibitors of factor Xa: optimization of the S4 ligand. Bioorg. Med. Chem. Lett. 2000, 10, 301-304.
23. De Lucca, G. V.; Kim, U. T.; Liang, J.; Cordova, B.; Klabe, R. M.; Garber, S.; Bacheler, L. T.; Lam, G. N.; Wright, M. R.; Logue, K. A.; Erickson-Viitanen, S.; Ko, S. S.; Trainor, G. L. Nonsymmetric P2/ P2′ Cyclic Urea HIV Protease Inhibitors. Structure-Activity Relationship, Bioavailability, and Resistance Profile of Monoindazole-Substituted P2 Analogues. J. Med. Chem. 1998, 41, 2411-2423.
24. Hodge, C. N.; Lam, P. Y. S.; Eyermann, C. J.; Jadhav, P. K.; Ru, Y.; Fernandez, C. H.; De Lucca, G. V.; Chang, C.-H.; Kaltenbach, R. F., III.; Holler, E. R.; Woerner, F.; Daneker, W. F.; Emmett, G.; Calabrese, J. C.; Aldrich, P. E. Calculated and Experimental Low-Energy Conformations of Cyclic Urea HIV Protease Inhibitors. J. Am. Chem. Soc. 1998, 120, 4570-4581.
25. Lam, P. Y. S.; Jadhav, P. K.; Eyermann, C. J.; Hodge, C. N.; Ru, Y.; Bachelor, L. T.; Meek, J. L.; Otto, M. J.; Rayner, M. M.; Wong, Y. N.; Chang, C.-H.; Weber, P. C. Nonpeptide cyclic ureas as HIV protease inhibitors. Science 1994, 263, 380-384.
26. Dougherty, J. M.; Probs, D. A.; Robinson, R. E.; Moore, J. D.; Klein, T. A.; Snelgrove, K. A.; Hanson, P. R. Ring-Closing Metathesis Strategies to Cyclic Sulfamide Peptidomimetics. Tetrahedron 2000, 56, 9781-9790.
27. Groutas, W. C.; Kuang, R.; Venkataraman, R.; Epp, J. B.; Ruan, S.; Prakash, O. Structure-Based Design of a General Class of Mechanism-Based Inhibitors of the Serine Proteinases Employing a Novel Amino Acid-Derived Heterocyclic Scaffold. Biochemistry 1997, 36, 4739-4750.
28. Kuang, R.; Epp, J. B.; Ruan, S.; Yu, H.; Huang, P.; He, S.; Tu, J.; Schechter, N. M.; Turbov, J.; Froelich, C. J.; Groutas, W. C. A General Inhibitor Scaffold for Serine Proteases with a (Chymo)trypsin-Like Fold: Solution-Phase Construction and Evaluation of the First Series of Libraries of Mechanism- Based Inhibitors. J. Am. Chem. Soc. 1999, 121, 8128-8129.
29. Groutas, W. C.; Kuang, R.; Ruan, S.; Epp, J. B.; Venkataraman, R.; Truong, T. M. Potent and Specific Inhibition of Human Leukocyte Elastase, Cathepsin G and Proteinase 3 by Sulfone Derivatives Employing the 1,2,5-Thiadiazolidin-3-one 1,1 Dioxide Scaffold. Bioorg. Med. Chem. 1998, 6, 661-671.
30. Boudjabi, S.; Dewynter, G.; Voyer, N.; Toupet, L.; Montero, J.-L. Sulfahydantoins as Tripeptide Constraints: Synthesis and Structure of Chiral Substituted 3-oxo-1,2,5-thiadiazolidine 1,1-dioxides. Eur. J. Org. Chem. 1999, 9, 2275-2283.
31. Shimshoni, J. A.; Bialer, M.; Wlodarczyk, B.; Finnell, R. H.; Yagen, B. Potent Anticonvulsant Urea Derivatives of Constitutional Isomers of Valproic Acid. J. Med. Chem. 2007, 50, 6419-6427.
32. Trojnar, M. K.; Wierzchowska-Cioch, E.; Krzyzanowski, M.; Jargiello, M.; Czuczwar, S. J. New generation of valproic acid. Pol. J. Phar-macol. 2004, 56, 283-288.
33. Hadad, S.; Bialer, M. Pharmacokinetic Analysis and Antiepileptic Activity of N-Valproyl Derivatives of GABA and Glycine. Pharm. Res. 1995, 12, 905-910.
34. Hadad, S.; Bialer, M. Pharmacokinetic Analysis and Antiepileptic Activity of Two New Isomers of N-Valproyl Glycinamide. Biopharm. Drug Dispos. 1997, 18, 557-566.
35. Isoherranen, N.; Woodhead, H. J.; White, H. S.; Bialer, M. Anticon-vulsant Profile of Valrocemide (TV1901): A New Antiepileptic Drug. Epilepsia 2001, 42, 831-836.
36. Dougherty, J. M.; Probst, D. A.; Robinson, R. E.; Moore, J. D.; Klein, T. A.; Snelgrove, K. A.; Hanson, P. R. Ring-Closing Metathesis Strategies to Cyclic Sulfamide Peptidomimetics. Tetrahedron 2000, 56, 9781-9790.
37. Dewynter, G.; Aouf, N.; Regainia, Z.; Montero, J.-L. Synthesis of pseudonucleosides containing chiral sulfahydantoins as aglycone (II). Tetrahedron 1996, 52, 993-1004.
38. Dewynter, G.; Aouf, N.; Criton, M.; Montero, J.-L. Synthèse de "sulfahydatoi'nes" chirales. Aspects stéréochimiques et protection régiospécifique. Tetrahedron 1993, 49, 65-76.
39. Mitsunobu, O. The Use of Diethyl Azodicarboxylate and Triph-enylphosphine in Synthesis and Transformation of Natural Products. Synthesis 1981, 1-28.
40. DuBois, G. E.; Stephenson, R. A. Sulfonylamine-mediated sulfamation of amines. A mild, high yield synthesis of sulfamic acid salts. J. Org. Chem. 1980, 45, 5371-5373.
41. DuBois, G. E. Amination of aryl sulfamate esters. A convenient general synthesis of aliphatic sulfamides. J. Org. Chem. 1980, 45 (26), 5373-5375.
42. Grimm, H. G. Structure and Size of the Non-Metallic Hydrides. Z. Electrochem. 1925, 31, 474-480.
43. Grimm, H. G. On the Systematic Arrangement of Chemical Compounds from the Perspective of Research on Atomic Composition and on Some Challenges in Experimental Chemistry. Z. Naturwiss. 1929, 17, 557-564.
44. Malawska, B.; Kulig, K.; Spiewak, A.; Stables, J. P. Investigation into new anticonvulsant derivatives of α-substituted N-benzylamides of γ-hydroxy- and γ-acetoxybutyric acid. Part 5: Search for new anticonvulsant compounds. Bioorg. Med. Chem. 2004, 12, 625-632.
45. Porter, M.; Cereghino, M.; Gladding, R.; Hessie, B.; Kupferberg, D.; Scoville, M.; White, D. Antiepileptic Drug Development Program. Cleveland Clin. Q. 1984, 51, 293-305.
46. Litchfield, J. T.; Wilcoxon, F. A simplified method of evaluating dose- effect experiments. J. Pharmacol. Exp. Ther. 1949, 96, 99-113.